Landmark medical advances create new policy challenges.
D000998:Antiviral Agents / Q000627:therapeutic use; D016527:Drug Costs; D004345:Drug Industry; D005380:Financing, Government; D015658:HIV Infections / Q000191:economics / Q000628:therapy*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D012109:Research Support as Topic; D014481:United States
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors